on Viemed Healthcare, Inc. (NASDAQ:VMD)
Viemed Healthcare Reports Strong Q2 2025 Financial Results
Viemed Healthcare, Inc. has announced its financial results for Q2 2025, marking a successful quarter. The company's net revenues reached $63.1 million, a 14.7% increase from Q2 2024. Net income also surged to $3.2 million, a 115.1% rise year-over-year. Adjusted EBITDA improved by 11.5% to $14.3 million.
The company repurchased 270,061 shares for $1.8 million. Patient counts for ventilator and PAP therapy increased by 11.4% and 51.4%, respectively, over the previous year. With $20.0 million in cash and $55 million in credit, Viemed maintains a robust financial position.
The recent acquisition of Lehan's Medical Equipment promises to boost full-year revenue and Adjusted EBITDA, with increased guidance reflecting anticipated synergies.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Viemed Healthcare, Inc. news